3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
13
Multiple Myeloma
3
Carcinoma, Renal Cell
3
Neoplasms
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Uveal Melanoma
1
Triple Negative Breast Neoplasms
1
Small Cell Lung Carcinoma
1
Recurrence
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Lymphoma, Follicular
1
Lymphoma
1
Lung Neoplasms
1
Leukemia-Lymphoma, Adult T-Cell
1
Leukemia
1
Hematologic Neoplasms
1
Breast Carcinoma In Situ
1
Interventions
Sunitinib
19
Everolimus
17
Bevacizumab
13
aldesleukin
11
Sorafenib
11
Interleukin-2
10
Cyclophosphamide
10
Axitinib
10
Nivolumab
9
fludarabine phosphate
7
fludarabine
7
pembrolizumab
5
Gemcitabine
5
temsirolimus
4
pazopanib
4
Ipilimumab
4
peginterferon alfa-2b
3
durvalumab
3
cabozantinib
3
Radiosurgery
3
Interferon-alpha
3
Granulocyte-Macrophage Colony-Stimulating Factor
3
Filgrastim
3
Erlotinib Hydrochloride
3
Cryosurgery
3
vandetanib
2
spartalizumab
2
perflutren
2
ixabepilone
2
chiron
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Kidney Neoplasms
×
Introns
×
Clear all
No trials found.